DYADIC INTERNATIONAL INC Operating Cash Flow
DYADIC INTERNATIONAL INC (DYAI) reported Operating Cash Flow of -$3.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-12
- DYADIC INTERNATIONAL INC net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.82M.
- DYADIC INTERNATIONAL INC net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.96M.
- DYADIC INTERNATIONAL INC net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.77M.
- DYADIC INTERNATIONAL INC net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.85M.
- DYADIC INTERNATIONAL INC net cash provided by (used in) operating activities for fiscal 2025 was -$5.70M.
- DYADIC INTERNATIONAL INC net cash provided by (used in) operating activities for fiscal 2024 was -$3.97M.
- DYADIC INTERNATIONAL INC net cash provided by (used in) operating activities for fiscal 2023 was -$6.73M.
- DYADIC INTERNATIONAL INC net cash provided by (used in) operating activities for fiscal 2022 was -$8.08M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.78M 10-Q · filed 2026-08-12 | -$5.55M derived: sum of 3 quarters · filed 2026-08-12 | -$7.40M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$1.96M 10-Q · filed 2026-05-13 | -$3.73M derived: sum of 2 quarters · filed 2026-05-13 | -$5.59M derived: sum of 3 quarters · filed 2026-05-13 | -$5.72M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$3.62M derived: sum of 2 quarters · filed 2026-03-25 | -$3.75M derived: sum of 3 quarters · filed 2026-08-12 | -$5.70M 10-K · filed 2026-03-25 | |
| 2025-09-30 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.98M derived: sum of 2 quarters · filed 2026-08-12 | -$3.93M 10-Q · filed 2025-11-12 | -$4.63M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | -$130.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.08M 10-Q · filed 2026-08-12 | -$2.78M derived: sum of 3 quarters · filed 2026-08-12 | -$2.98M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$1.95M 10-Q · filed 2026-05-13 | -$2.65M derived: sum of 2 quarters · filed 2026-05-13 | -$2.85M derived: sum of 3 quarters · filed 2026-05-13 | -$4.81M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$696.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$897.45K derived: sum of 2 quarters · filed 2026-03-25 | -$2.86M derived: sum of 3 quarters · filed 2026-03-25 | -$3.97M 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$201.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.17M derived: sum of 2 quarters · filed 2025-11-12 | -$3.28M 10-Q · filed 2025-11-12 | -$4.20M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$3.08M 10-Q · filed 2025-08-13 | -$4.00M derived: sum of 3 quarters · filed 2025-08-13 | -$5.96M derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$1.11M 10-Q · filed 2025-05-14 | -$2.04M derived: sum of 2 quarters · filed 2025-05-14 | -$4.00M derived: sum of 3 quarters · filed 2025-05-14 | -$5.65M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | -$923.38K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$2.89M derived: sum of 2 quarters · filed 2025-03-26 | -$4.54M derived: sum of 3 quarters · filed 2025-03-26 | -$6.73M 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$3.62M derived: sum of 2 quarters · filed 2024-11-12 | -$5.80M 10-Q · filed 2024-11-12 | -$7.49M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$3.84M 10-Q · filed 2024-08-13 | -$5.52M derived: sum of 3 quarters · filed 2024-08-13 | -$7.30M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$2.19M 10-Q · filed 2024-05-14 | -$3.87M derived: sum of 2 quarters · filed 2024-05-14 | -$5.64M derived: sum of 3 quarters · filed 2024-05-14 | -$7.42M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$3.46M derived: sum of 2 quarters · filed 2024-03-28 | -$5.23M derived: sum of 3 quarters · filed 2024-03-28 | -$8.08M 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$3.55M derived: sum of 2 quarters · filed 2023-11-08 | -$6.40M 10-Q · filed 2023-11-08 | -$9.04M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$4.63M 10-Q · filed 2023-08-09 | -$7.26M derived: sum of 3 quarters · filed 2023-08-09 | -$11.59M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | -$2.85M 10-Q · filed 2023-05-10 | -$2.85B 10-Q · filed 2022-05-12 | -$5.49M derived: sum of 2 quarters · filed 2023-05-10 | -$9.82M derived: sum of 3 quarters · filed 2023-05-10 | $1.89B derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$6.97M derived: sum of 2 quarters · filed 2023-03-29 | $1.90B derived: sum of 3 quarters · filed 2023-03-29 | -$11.28M 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.90B derived: sum of 2 quarters · filed 2022-11-10 | -$8.64M 10-Q · filed 2022-11-10 | -$9.93M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $1.90B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$4.31M 10-Q · filed 2022-08-10 | -$5.59M derived: sum of 3 quarters · filed 2022-08-10 | -$6.98M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | -$1.91B 10-Q · filed 2022-05-12 | -$1.91M 10-Q · filed 2021-05-13 | -$1.91B derived: sum of 2 quarters · filed 2022-05-12 | -$1.91B derived: sum of 3 quarters · filed 2022-05-12 | -$1.91B derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$2.67M derived: sum of 2 quarters · filed 2022-03-29 | -$4.58M derived: sum of 3 quarters · filed 2022-03-29 | -$6.57M 10-K · filed 2022-03-29 | |
| 2020-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$3.29M derived: sum of 2 quarters · filed 2021-11-10 | -$5.29M 10-Q · filed 2021-11-10 | -$6.69M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$3.90M 10-Q · filed 2021-08-12 | -$5.30M derived: sum of 3 quarters · filed 2021-08-12 | -$6.85M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$2.00M 10-Q · filed 2021-05-13 | -$3.40M derived: sum of 2 quarters · filed 2021-05-13 | -$4.94M derived: sum of 3 quarters · filed 2021-05-13 | -$6.37M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$2.94M derived: sum of 2 quarters · filed 2021-03-30 | -$4.37M derived: sum of 3 quarters · filed 2021-03-30 | -$5.78M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$2.97M derived: sum of 2 quarters · filed 2020-11-12 | -$4.38M 10-Q · filed 2020-11-12 | -$5.61M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$2.84M 10-Q · filed 2020-08-13 | -$4.07M derived: sum of 3 quarters · filed 2020-08-13 | -$4.87M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | -$1.41M 10-Q · filed 2020-05-14 | -$2.64M derived: sum of 2 quarters · filed 2020-05-14 | -$3.44M derived: sum of 3 quarters · filed 2020-05-14 | -$5.16M derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$2.03M derived: sum of 2 quarters · filed 2020-03-30 | -$3.75M derived: sum of 3 quarters · filed 2020-03-30 | -$4.41M 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$801.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$2.52M derived: sum of 2 quarters · filed 2019-11-13 | -$3.18M 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$2.38M 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | -$660.76K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | -$1.69M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |